MRNA

Moderna, Inc.

86.93 USD
-1.44 (-1.63%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Moderna, Inc. stock is down -12.81% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Feb 17:03 23 Feb, 2024 90.00 CALL 100 493
20 Feb 17:03 01 Mar, 2024 95.00 CALL 156 294
20 Feb 17:27 01 Mar, 2024 88.00 CALL 57 58
20 Feb 18:14 23 Feb, 2024 85.00 PUT 154 1639
20 Feb 18:18 20 Sep, 2024 100.00 CALL 25 108
20 Feb 18:37 20 Sep, 2024 100.00 CALL 33 108
20 Feb 19:31 19 Jul, 2024 115.00 CALL 61 639
20 Feb 19:33 17 Jan, 2025 105.00 CALL 46 1503
20 Feb 20:09 22 Mar, 2024 70.00 CALL 18 0
20 Feb 20:35 19 Jul, 2024 75.00 PUT 250 2498

About Moderna, Inc.

Moderna, Inc. develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. The company has 44 development programs, which includes 26 in clinical trials across seven modalities.